Skip to content

Clinical trials

Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 3 Country / region: Poland Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20071
20081
20094
20111
20124
20136
20144
20154
20161
20172
20182
20192
20201
20213
20223
20233
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting14
Recruiting8
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences6
BeOne Medicines5
Hoffmann-La Roche5
Acerta Pharma BV4
Loxo Oncology, Inc.4
Pharmacyclics LLC.4
Janssen Research & Development, LLC3
Novartis Pharmaceuticals3
AbbVie2
BeiGene2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell49
Lymphoma, Non-Hodgkin6
Hematologic Diseases4
Leukemia4
Leukemia, B-Cell4
Lymphoma, B-Cell4
Lymphoma, Follicular4
Neoplasms4
Recurrence4
Agammaglobulinemia3

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.